Asensus Surgical

Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System features a machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling on August 19, 1988 and is headquartered in Durham, NC.

Earnings data Q2 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Asensus Surgical, Inc. (NYSE:ASXC ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Mark Klausner - Westwicke Partners Anthony Fernando - President, CEO & Director Shameze Rampertab - EVP & CFO Conference Call Participants Ross Osborn - Cantor Fitzgerald Li Chen - H.C. Wainwright & Co. RK Ramakanth - H.C.

Asensus Surgical, Inc. (ASXC) Q1 2023 Earnings Call Transcript

Asensus Surgical (ASXC) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.07 per share a year ago.

Asensus Surgical (ASXC) Reports Q1 Loss, Misses Revenue Estimates

RESEARCH TRIANGLE PARK, N.C., April 27, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™ (PGS), announced today that it plans to release 2023 first quarter financial and operating results after the market closes on Thursday, May 11, 2023. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be concurrently webcast.

Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 11, 2023

System to be Utilized by the Second Largest Private Hospital System in Japan System to be Utilized by the Second Largest Private Hospital System in Japan

Asensus Surgical Announces Fukuoka Tokushukai Hospital in Japan to Initiate Senhance Surgery Program

RESEARCH TRIANGLE PARK, N.C., April 19, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the H.C. Wainwright In-Person Bio-Connect Investor Conference. The Company's fireside chat will take place on Tuesday, May 2, 2023 at 11:30 am Eastern Time.

Asensus Surgical to Participate in the H.C. Wainwright In-Person BioConnect Investor Conference

Allarity Therapeutics

INVO Bioscience

Penny stocks under $1 to watch this week. The post Best Penny Stocks To Buy?

Best Penny Stocks To Buy? 3 Under $0.99 To Watch Now

Senhance Offers the First and Only Digital Laparoscopic Surgery Solution for Pediatric Patients Senhance Offers the First and Only Digital Laparoscopic Surgery Solution for Pediatric Patients

Asensus Surgical Receives FDA 510(k) Clearance For Pediatric Indication for Senhance Surgical System

Adial Pharmaceuticals Inc

Akebia Therapeutics

Borqs Technologies

Blue Star Foods Corp

Kiromic Biopharma

Myomo

Novo Integrated Sciences, Inc.

Sono Group NV

vTv Therapeutics

Penny stocks under $1 to watch right now. The post 10 Hot Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

10 Hot Penny Stocks Under $1 To Watch This Week

Penny stocks under $1 to watch this week. The post 7 Hot Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

7 Hot Penny Stocks Under $1 To Watch This Week

RESEARCH TRIANGLE PARK, N.C., March 06, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Oppenheimer 33rd Annual Healthcare Conference. The Company's virtual presentation will take place on Monday, March 13 at 2:00 pm Eastern Time.

Asensus Surgical to Participate in the Oppenheimer 33rd Annual Healthcare Conference

Asensus Surgical (ASXC) delivered earnings and revenue surprises of 0% and 1.44%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Asensus Surgical (ASXC) Reports Q4 Loss, Lags Revenue Estimates

RESEARCH TRIANGLE PARK, N.C., March 02, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™(PGS), today announced its operating and financial results for the fourth quarter and full year 2022.

Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2022

RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release fourth quarter and full year 2022 financial and operating results after the market closes on Thursday, March 2, 2023.

Asensus Surgical, Inc. to Release Fourth Quarter and Full Year 2022 Financial and Operating Results on March 2, 2023

Amyris

AMTD International Inc

LM Funding America

Mobilicom 

Sidus Space

Sorrento Therapeutics

Will penny stock news put these on your buy or sell list this week? The post Penny Stocks To Buy?

Penny Stocks To Buy? 7 To Watch Now After Big News

RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, is providing this corporate update in conjunction with its previously announced Investor Day, which will be hosted today, beginning at 11:30am EST.

Asensus Surgical Provides Corporate Update

Penny stocks with big news in February 2023. Are they the best to buy now?

Best Penny Stocks To Buy Now? 4 With Big News In February

The Companies intend to collaborate on developing next-generation instrumentation and KARL STORZ intends to sell Asensus' Intelligent Surgical Unit (ISU) as a standalone device The Companies intend to collaborate on developing next-generation instrumentation and KARL STORZ intends to sell Asensus' Intelligent Surgical Unit (ISU) as a standalone device

Asensus and KARL STORZ to Market the Intelligent Surgical Unit and Co-Develop New Vision and Instrument Platforms

RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, today announced a multi-year collaboration with Google Cloud to integrate Google Cloud's secure cloud data architecture and machine learning (ML) technologies to further expand the capabilities of the Asensus Surgical's Performance-Guided Surgery™ (PGS) framework enabled through the Intelligent Surgical Unit ™ (ISU™).

Asensus Surgical Announces Machine Learning and Cloud Infrastructure Collaboration with Google Cloud to Advance Performance-Guided Surgery

RESEARCH TRIANGLE PARK, N.C., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, today announced that President and CEO Anthony Fernando will be joined by other leaders of the Company to ring the opening bell of the New York Stock Exchange on February 21, 2023. On the same day, the Company is hosting an Investor Day.

Asensus Surgical to Ring New York Stock Exchange Opening Bell on February 21, 2023

RESEARCH TRIANGLE PARK, N.C., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the Company will host an Investor Day on Tuesday, February 21, 2023 in New York City.

Asensus Surgical to Host Investor Day on February 21, 2023

Avaya Holdings

Cenntro Electric Group Ltd

PolyPid

Troika Media Group

Lightning eMotors, Inc

Penny stocks under $1 to watch right now. The post 7 Top Penny Stocks Under $1 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

7 Top Penny Stocks Under $1 To Watch Before Next Week

Expanded Intelligent Surgical Unit™ (ISU™) capabilities include 3D measurement, digital tagging, image enhancement, and enhanced camera control, for our European customers Expanded Intelligent Surgical Unit™ (ISU™) capabilities include 3D measurement, digital tagging, image enhancement, and enhanced camera control, for our European customers

Asensus Surgical Receives CE Mark for Expanded Machine Vision Capabilities

RESEARCH TRIANGLE PARK, N.C., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today provided a preliminary 2022 year-end corporate update.

Asensus Surgical Provides Preliminary 2022 Year-End Corporate Update

RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the management team will participate and present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 12:00 PM PST.

Asensus Surgical, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference

First hospital to install a second Senhance Surgical System First hospital to install a second Senhance Surgical System

News for Asensus Surgical Stock (ASXC)